인쇄하기
취소
|
SK Chemicals acquired a permit to commercialize the first generic of ‘Vimpat Tab(lacosamide)’ that is known as a next-generation epilepsy therapy.
According to the industry on the 1st, SK Chemicals acquired approval of ‘Vimsk Tab,’ a Vimpat’s generic drug, on the 31st for the first time in Korea.
Vimpat, a product launched by Korea UBC on December 2011, is used as an addition therapy to treat...